BCI
CBAY

Brinker Capital Investments’s Cymabay Therapeutics CBAY Stock Holding History

Brinker Capital Investments’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,357
Closed -$291K – 1765
2023
Q4 		$291K Sell
12,357
-2,977
-19% -$53K ﹤0.01% 1414
2023
Q3 		$229K Buy
+15,334
New +$203K ﹤0.01% 1497

Other funds holding CBAY

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Brinker Capital Investments's CBAY Position: Q1 2024 in Review

Brinker Capital Investments sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 12,357 shares — an estimated $291K sold.

Brinker Capital Investments first reported a position in CBAY in Q3 2023 and held it in 2 quarters. The position peaked at $291K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

  • Brinker Capital Investments reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Brinker Capital Investments sold 12,357 Cymabay Therapeutics shares in Q1 2024, an estimated $291K.
  • Brinker Capital Investments first reported a position in Cymabay Therapeutics in Q3 2023 and held it in 2 quarters.
  • Brinker Capital Investments's Cymabay Therapeutics position peaked at $291K in Q4 2023.
  • 1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Brinker Capital Investments's 13F filing for Q1 2024, filed 31 Jul 2025.